159 related articles for article (PubMed ID: 26215394)
21. Intratumoral Canine Distemper Virus Infection Inhibits Tumor Growth by Modulation of the Tumor Microenvironment in a Murine Xenograft Model of Canine Histiocytic Sarcoma.
Armando F; Fayyad A; Arms S; Barthel Y; Schaudien D; Rohn K; Gambini M; Lombardo MS; Beineke A; Baumgärtner W; Puff C
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808256
[TBL] [Abstract][Full Text] [Related]
22. Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles.
Autio K; Knuuttila A; Kipar A; Pesonen S; Guse K; Parviainen S; Rajamäki M; Laitinen-Vapaavuori O; Vähä-Koskela M; Kanerva A; Hemminki A
Mol Ther Oncolytics; 2014; 1():14002. PubMed ID: 27119092
[TBL] [Abstract][Full Text] [Related]
23. High prevalence of antibodies against canine adenovirus (CAV) type 2 in domestic dog populations in South Africa precludes the use of CAV-based recombinant rabies vaccines.
Wright N; Jackson FR; Niezgoda M; Ellison JA; Rupprecht CE; Nel LH
Vaccine; 2013 Aug; 31(38):4177-82. PubMed ID: 23867013
[TBL] [Abstract][Full Text] [Related]
24. Production of defective interfering virus in the brains of mice by an avirulent, in contrast with a virulent, strain of Semliki forest virus.
Woodward CG; Smith H
Br J Exp Pathol; 1975 Aug; 56(4):363-72. PubMed ID: 1174462
[TBL] [Abstract][Full Text] [Related]
25. A live-attenuated influenza vaccine for H3N2 canine influenza virus.
Rodriguez L; Nogales A; Reilly EC; Topham DJ; Murcia PR; Parrish CR; Martinez Sobrido L
Virology; 2017 Apr; 504():96-106. PubMed ID: 28167384
[TBL] [Abstract][Full Text] [Related]
26. Investigations of reasons for the avirulence of the A7 strain of Semliki Forest virus in adult mice.
Woodward CG; Marshall ID; Smith H
Br J Exp Pathol; 1977 Dec; 58(6):616-24. PubMed ID: 607983
[TBL] [Abstract][Full Text] [Related]
27. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent.
Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA
Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014
[TBL] [Abstract][Full Text] [Related]
28. Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine Cancer.
Naik S; Galyon GD; Jenks NJ; Steele MB; Miller AC; Allstadt SD; Suksanpaisan L; Peng KW; Federspiel MJ; Russell SJ; LeBlanc AK
Mol Cancer Ther; 2018 Jan; 17(1):316-326. PubMed ID: 29158470
[TBL] [Abstract][Full Text] [Related]
29. Following Acute Encephalitis, Semliki Forest Virus is Undetectable in the Brain by Infectivity Assays but Functional Virus RNA Capable of Generating Infectious Virus Persists for Life.
Fragkoudis R; Dixon-Ballany CM; Zagrajek AK; Kedzierski L; Fazakerley JK
Viruses; 2018 May; 10(5):. PubMed ID: 29783708
[TBL] [Abstract][Full Text] [Related]
30. Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines.
Withoff S; Glazenburg KL; van Veen ML; Kraak MM; Hospers GA; Störkel S; de Vries EG; Wilschut J; Daemen T
Gene Ther; 2001 Oct; 8(20):1515-23. PubMed ID: 11704811
[TBL] [Abstract][Full Text] [Related]
31. Functional significance of the nuclear-targeting and NTP-binding motifs of Semliki Forest virus nonstructural protein nsP2.
Rikkonen M
Virology; 1996 Apr; 218(2):352-61. PubMed ID: 8610462
[TBL] [Abstract][Full Text] [Related]
32. The Semliki Forest virus E2 gene as a virulence determinant.
Santagati MG; Määttä JA; Itäranta PV; Salmi AA; Hinkkanen AE
J Gen Virol; 1995 Jan; 76 ( Pt 1)():47-52. PubMed ID: 7844541
[TBL] [Abstract][Full Text] [Related]
33. Aurothiolates enhance the replication of Semliki Forest virus in the CNS and the exocrine pancreas.
Scallan MF; Fazakerley JK
J Neurovirol; 1999 Aug; 5(4):392-400. PubMed ID: 10463861
[TBL] [Abstract][Full Text] [Related]
34. Adoptive transfer of immunity against virulent Semliki Forest virus with immune spleen cells from mice infected with avirulent Semliki Forest virus.
Kraaijeveld CA; Benaissa-Trouw BJ; Harmsen M; Snippe H
Arch Virol; 1986; 91(1-2):83-92. PubMed ID: 3489451
[TBL] [Abstract][Full Text] [Related]
35. Osteosarcoma cells as carriers to allow antitumor activity of canine oncolytic adenovirus in the presence of neutralizing antibodies.
Alcayaga-Miranda F; Cascallo M; Rojas JJ; Pastor J; Alemany R
Cancer Gene Ther; 2010 Nov; 17(11):792-802. PubMed ID: 20671769
[TBL] [Abstract][Full Text] [Related]
36. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection.
Subak-Sharpe I; Dyson H; Fazakerley J
J Virol; 1993 Dec; 67(12):7629-33. PubMed ID: 7901429
[TBL] [Abstract][Full Text] [Related]
37. Use of N-acetylethyleneimine [AEI] for the inactivation of Semliki Forest virus in vitro.
Amor S; Webb HE
J Med Virol; 1986 Aug; 19(4):367-76. PubMed ID: 3746260
[TBL] [Abstract][Full Text] [Related]
38. Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles.
Brand D; Lemiale F; Turbica I; Buzelay L; Brunet S; Barin F
AIDS Res Hum Retroviruses; 1998 Oct; 14(15):1369-77. PubMed ID: 9788678
[TBL] [Abstract][Full Text] [Related]
39. Preclinical Testing Oncolytic Vaccinia Virus Strain GLV-5b451 Expressing an Anti-VEGF Single-Chain Antibody for Canine Cancer Therapy.
Adelfinger M; Bessler S; Frentzen A; Cecil A; Langbein-Laugwitz J; Gentschev I; Szalay AA
Viruses; 2015 Jul; 7(7):4075-92. PubMed ID: 26205404
[TBL] [Abstract][Full Text] [Related]
40. Prevention of death in Semliki Forest virus-infected mice by administration of defective-interfering Semliki Forest virus.
Dimmock NJ; Kennedy SI
J Gen Virol; 1978 May; 39(2):231-42. PubMed ID: 650175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
